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ABSTRACT 
The Salmonella secreted effector 
SseK3 translocates into the host cells, 
targeting innate immune responses 
including NF-κB activation. SseK3 is a 
glycosyltransferase that transfers an N-
acetylglucosamine (GlcNAc) moiety onto 
the guanidino group of a target arginine, 
modulating host cell function. However, a 
lack of structural information has precluded 
elucidation of the molecular mechanisms in 
arginine and GlcNAc selection. We report 
here the crystal structure of SseK3 in its 
apo form and in complex with hydrolysed 
UDP-GlcNAc. SseK3 possesses the typical 
glycosyltransferase type-A (GT-A)-family 
fold and the metal-coordinating DXD motif 
essential for ligand binding and enzymatic 
activity. Several conserved residues were 
essential for arginine-GlcNAcylation and 
SseK3-mediated inhibition of NF-κB 
activation. Isothermal titration calorimetry 
revealed SseK3’s preference for manganese 
coordination. The pattern of interactions in 
the substrate-bound SseK3 structure 
explained the selection of the primary 
ligand. Structural re-arrangement of the C-
terminal residues upon ligand binding was 
crucial for SseK3’s catalytic activity and 
NMR analysis indicated that SseK3 has 
limited UDP-GlcNAc hydrolysis activity. 
The release of free N-acetyl α-D-
glucosamine, and the presence of the same 
molecule in the SseK3 active site, classified 
it as a retaining glycosyltransferase. A 
glutamate residue in the active site 
suggested a double-inversion mechanism 
for the arginine N-glycosylation reaction. 
Homology models of SseK1, SseK2, and 
the Escherichia coli orthologue NleB1, 
disclosed differences in the surface 
electrostatic charge distribution possibly 
accounting for their diverse activities. This 
first structure of a retaining GT-A arginine 
N-glycosyltransferase provides an 
important step towards a better 
understanding of this enzyme class and 
their roles as bacterial effectors. 
 
 
Salmonella enterica is an intracellular 
Gram-negative pathogen for which strains 
of the various serovars cause many diseases 
in humans and animals worldwide. In 
immune-competent humans, non-typhoidal 
Salmonella (NTS) serovars, including 
Salmonella enterica serovar Typhimurium, 
typically cause self-limiting gastroenteritis 
(1). However, in immune-compromised 
individuals, NTS serovars frequently cause 
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an invasive disease that results in 
significant morbidity (2). 
Following invasion or phagocytic uptake 
into the host cell, one of the key virulence 
determinants is the Salmonella 
pathogenicity island 2 (SPI-2)-encoded type 
III secretion system (T3SS), which delivers 
approximately 28 effector proteins into the 
host cell (3-5). A number of Salmonella 
effectors target and modify host proteins 
that have a role in mediating host 
inflammatory responses (3,6). Three highly 
related Salmonella effectors, SseK1, SseK2 
and SseK3, orthologues of the 
enteropathogenic and enterohemorrhagic 
Escherichia coli T3SS effector NleB1 (7), 
translocate via the T3SS into the host cell 
(8). Similarly to NleB1 (9,10), SseK1 and 
SseK3 are N-acetylglucosamine (GlcNAc) 
transferases that modify the TNFR1-
associated death domain protein TRADD 
and inhibit activation of the pro-
inflammatory transcription factor NF-κB, 
as well as necroptotic host cell death (8). In 
in vitro experiments, SseK2 modifies the 
FAS-associated protein with death domain 
(FADD) (11) but despite detectable 
translocation into host cells, SseK2 is only 
able to inhibit NF-κB when highly 
overexpressed in 293ET cells (8). This 
suggests that either a loss of catalytic 
activity or of substrate interaction occurs 
after delivery of physiologically relevant 
levels of SseK2. Whether SseK2 has 
unidentified functions during infection that 
are mediated by different targets or a 
different sugar modification remains 
unknown.  
Unlike mammalian O-linked 
GlcNAcylation, where GlcNAc is attached 
to the oxygen of the hydroxyl group of 
serine and threonine residues of numerous 
cytosolic and nuclear proteins, including 
those that mediate signalling (12), 
GlcNAcylation mediated by NleB from 
pathogenic E. coli or SseK bacterial 
effectors results in addition of GlcNAc to 
arginine residues with a N-glycosidic 
linkage (9,10). This distinct modification 
can be recognized in mammalian cells 
using an antibody that does not detect O-
linked GlcNAcylation (13). Both, 
mammalian GlcNAcylation and bacterial-
mediated arginine-GlcNAcylation, involves 
the transfer of sugar from an activated 
uridine-diphosphate carbohydrate donor 
substrate, UDP-GlcNAc. NleB and SseK 
proteins have a conserved DXD motif, 
typical of GT-A family of 
glycosyltransferases, where the aspartic 
side chains are required for the coordination 
of a metal divalent cation necessary for 
their enzymatic activity (14).  
Whilst, to date, there are a number of 
structures describing O-
glycosyltransferases, and the O-
GlcNAcylation catalytic event, the only 
known structure of a bacterial arginine-
specific glycosyltransferase is that of the B 
pattern-type inverting glycosyltransferase 
EarP, which modifies translation elongation 
factor P (EF-P) by arginine rhamnosylation 
(15,16). Another study reported 
glucosylation of arginine by the sweet corn 
protein amylogenin, which mediates self-
glucosylation in vitro (17), but there have 
been no follow up reports.  
Sequence analysis suggests a structure for 
the catalytic core of NleB1 protein similar 
to that of Photorhabdus asymbiotica 
tyrosine-glycosyltransferase protein toxin 
(18) and Clostridium difficile toxin A and 
toxin B (19,20), which glycosylate host 
Rho GTPases involved in the regulation of 
the host cytoskeleton, and the Legionella 
pneumophila Lgt1 that targets a serine 
residue of eEF1A, blocking protein 
biosynthesis (21). As well as the conserved 
DXD motif in SseK effectors, additional 
amino acids are conserved, including a 
tyrosine and glutamic acid residue, 
equivalent to Y219 and E253 in NleB1, 
both required for NleB1-mediated arginine-
GlcNAcylation of the death-domain 
containing protein, FADD (22). Arginine-
GlcNAcylation of target proteins is not 
observed in un-infected host cells and is 
irreversible by host enzymes (23) and 
therefore represents a potent bacterial-
mediated virulence mechanism. However, 
in the absence of structural information, the 
molecular details underlying arginine and 
UDP-GlcNAc selection are unknown.  
This study presents the crystal structures of 
the N-glycosyltransferase SseK3 in its free 
form and bound to UDP, GlcNAc and 
manganese. SseK3 adopts the classical GT-
A glycosyltransferases family fold and is 
able to hydrolyse UDP-GlcNAc in the 
absence of a protein substrate. Mutational 
SseK3 is a retaining type-A glycosyltransferase	  
	  
3	  
	  
analysis of amino acids predicted to be 
important for substrate binding identified 
several conserved residues in SseK3 that 
are essential for arginine-GlcNAcylation of 
TRADD and SseK3-mediated inhibition of 
TNFα-induced NF-κB activation, directly 
correlating enzymatic activity to virulence 
function. Structural analysis reveals the 
presence of an active site glutamate residue, 
which is conserved only in NleB and SseK 
proteins but not in other structurally related 
glycosyltransferases, and is essential for 
enzymatic activity. The close proximity of 
this residue to the reactive anomeric carbon 
supports a double inversion catalytic 
mechanism where an intermediate enzyme-
sugar is stabilised for the nucleophilic 
attack of the acceptor arginine side chain of 
the host substrates. This is the first structure 
of a retaining arginine glycosyltransferase 
bound to a hydrolysed form of its donor 
substrate representing an important step 
towards the understanding of this class of 
effector proteins.  
 
Results 
A divalent cation is necessary for binding 
of the ligand to SseK3 
Mass spectrometry analysis of bacterially 
expressed full length SseK3 revealed 
limited proteolysis, with the protein losing 
its first 13 and last 2 amino acids (data not 
shown). For the majority of T3SS effector 
proteins, the N-terminal 15-25 residues, 
often predicted to be unstructured, are 
required for translocation and remain 
uncleaved following delivery into the host 
cell cytosol (24,25). This region is 
frequently removed prior to crystallisation, 
as in the case of the E. coli effector protease 
NleC (26), or disordered, as in the case of 
E. coli virulence factor NleE (27). We 
therefore, prepared two forms of SseK3, 
14-333 and 14-335, for subsequent 
structural and functional characterization. 
Glycosyltransferases require the presence 
of a divalent cation for activity. To test the 
selectivity of SseK3 for divalent cations 
and UDP-glucose derivatives we compared 
the ability of SseK3 to interact with Mg2+, 
Mn2+ and 3 UDP-carbohydrate derivatives: 
UDP-GlcNAc, UDP-Glc (glucose) and 
UDP-Gal (galactose) by isothermal titration 
calorimetry (ITC) (Figure 1 and S1, Table 
1). No binding was observed for UDP-
GlcNAc to SseK314-335 in the absence of a 
coordinating metal cation (Figure S1). 
When the titration experiments were 
performed in the presence of MgCl2 or 
MnCl2, the resulting binding affinity for 
UDP-GlcNAc in the presence of Mn2+ (Kd 
= 1.9 µM) showed a 5-fold increase 
compared to that for Mg2+ (Kd = 10 µM) 
(Figure 1 and S1). This binding affinity is 
similar to that observed for C. difficile toxin 
A for UDP-Glc and manganese (Kd = 11.4 
µM) (28). The binding studies showed that 
ligand interaction is influenced by the 
presence of the two C-terminal residues in 
the longer SseK3 construct (W334 and 
R335), but both SseK314-333 and SseK314-335 
bind with a lower affinity to UDP-Gal, 
compared to UDP-Glc and UDP-GlcNAc. 
UDP-GlcNAc has the highest affinity for 
SseK314-335, although only binds marginally 
stronger than UDP-Glc, and manifests the 
largest increase in affinity due to the 
presence of the two C-terminal residues 
W334 and R335. Interestingly, the change 
in affinity appears to be associated with an 
increase in binding enthalpy and a loss of 
entropy suggesting the occurrence of a 
structural reorganization upon ligand 
binding to SseK3 (Table 1).  
 
Structure of SseK3 
Crystals of SseK314-333 enriched with 
seleno-methionine diffracted to good 
resolution but most of them exhibited 
severe anisotropy, were non-isomorphous 
and showed translational non-
crystallographic symmetry. Attempts to 
solve the structure by molecular 
replacement using available 
glycosyltransferase X-ray structures or 
selenium SAD phasing failed. Instead, we 
recorded data at the I23 long-wavelength 
beamline at Diamond Light Source to 
reveal the positions of the selenium and 
sulphur atoms within SseK3 based on the 
small anomalous signals present at long 
wavelengths to obtain an initial model (29). 
This model was used as template in a 
molecular replacement search with a 
complete 2.21 Å resolution dataset that did 
not exhibit severe diffraction anisotropy. 
SseK314-333 crystal belongs to space group 
P212121 with 2 molecules in the asymmetric 
unit (a.u.) (Table 2) that overlap with a root 
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mean square deviation (RMSD) (Cα of 
residues 27-328) of 0.91 Å. The structure of 
apo SseK314-333 is reported in Figure 2A. 
Residues 14-25 are not visible in the 
electronic density for either chain, nor are 
amino acids 329-333 of chain B and the last 
serine residue (S333) of chain A. 
The structure of SseK314-335 at 2.20 Å in 
complex with UDP, GlcNAc and Mn2+ 
(Figure 2B) was solved by molecular 
replacement using the apo structure. 
SseK314-335 crystals belong to the same 
space group as the shorter unbound 
construct, with 2 molecules in the 
asymmetric unit (Table 2). The two chains 
in the a.u. overlap with a RMSD in Cα 
positions of 0.88 Å for residues 27-335. No 
electronic density is visible for amino acids 
14-26 for either chain in the a.u. whilst all 
the C-terminal residues are observable. 
Residues 27-321 of SseK3 in the apo and 
ligand-bound forms overlap with a RMSD 
of 0.84 Å while residues 322-332 of 
SseK314-333 are unstructured with an 
average B factor of 45.5 Å2, compared to 
the average macromolecule B factor of 33.3 
Å2. 
The SseK3 catalytic core domain (ca. 250 
residues) shows the classic features of the 
large glycosyltransferase type-A family of 
enzymes (GT-A) consisting of a single 
module composed of a central parallel β-
sheet core flanked by a number of α-helices 
(14). The structure contains an additional 
small domain, spanning residues 134-171, 
containing two extra α-helices that are here 
named α-helical insertion (Figure 2). This 
protruding region, especially the position of 
the residues in the loop 148-154, is 
differently tilted in the two SseK3 copies 
present in the crystallographic asymmetric 
unit, most likely due to non-identical crystal 
contacts. 
Using the structure of SseK314-335 as 
template, a DALI (30) search for 
homologous structures yielded high scores 
of 17.4, 16.9, 16.7 and 16.2 for the GT-A 
family members lethal toxin (LT) from C. 
sordelii in complex with UDP-Glc (PDB: 
2VKD) (31), P. asymbiotica ToxG bound 
to UDP-GlcNAc (PDB: 4MIX) (18), C. 
difficile toxin A bound to UDP-Glc (PDB: 
3SRZ) (20) and C. difficile toxin B bound 
to UDP and Glc (PDB: 2BVL) (19), 
respectively. According to the 
Carbohydrate-Active Enzymes (CAZY) 
database (32), all these enzymes are 
classified as sugar stereochemistry retaining 
glycosyltransferases. 
Due to the length of the crystallization 
process, and to the hydrolysis capabilities 
of SseK314-335, in the structure co-
crystallized in the presence of UDP-
GlcNAc and Mn2+, the ligand is hydrolysed 
with the UDP and N-acetyl α-D-
glucosamine still present in the active site 
(Figure 2B and S2). A similar observation 
was made for C. difficile toxB co-
crystallized in the presence of UDP-Glc 
(19). A comparison with the apo structure, 
reveals that the C-terminal amino acids in 
the ligand-bound SseK3 fold back onto the 
ligand to produce a short segment of α-
helix, with the last two residues W334 and 
R335 directly interacting with the UDP and 
GlcNAc (Figure 3B and 3C). 
To investigate the conformation of this C-
terminal region in the apo state we recorded 
a 1D proton NMR spectrum of apo 
SseK314-335. The spectrum has a downfield 
region, encompassing resonances from the 
backbone and side chain amides and 
aromatic side chain aliphatic protons that 
show an overall chemical shift dispersion 
typical of a folded protein (Figure 3D). The 
spectrum has a surprising number of sharp 
resonances, including a signal at 10 ppm, 
absent in the spectrum of SseK314-333 
(Figure S2C), likely corresponding to the 
side chain Hε1 of the C-terminal residue 
W334. The sharp signals in the spectrum of 
the free protein are broadened when UDP-
GlcNAc and MgCl2 are added to the 
solution suggesting a conformational 
rearrangement and loss of flexibility. Re-
organization of the C-terminus in the SseK3 
structure upon ligand binding correlates 
both with the NMR downfield resonances 
collapse in the 1D proton spectrum and 
with the loss of entropy upon binding 
detected by the ITC experiments. 
 
The active site 
SseK3 contains the classic GT-A DXD 
motif (D226AD228) that coordinates the 
divalent manganese cation in an octahedral 
geometry (Figures 3A and 3B). Mn2+ 
interacts with the carboxylate oxygens of 
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D228 and D325, the UDP diphosphate and 
the hydroxyl group of S327, as well as an 
ordered water molecule, which bridges, via 
hydrogen bonds, the metal atom and the 
carboxyl group of D226 of the DXD motif 
(Figure 3B). All the metal coordinating 
residues are conserved across this effector 
family apart from SseK3 D325 that is an 
asparagine residue in the other family 
members (Figure 3A). Most C-terminal 
residues participate in interactions that lock 
the phosphate groups in the correct 
orientation. S333, W334 and R335 all 
interact via hydrogen bonds with the 
oxygen atoms of the diphosphate. The last 
residue visible in the structure of SseK314-
333, serine 332, translates 17 Å from its 
position in the apo structure to interact 
directly with a β-oxygen of the UDP 
(Figure 3B). 
The aromatic portion of the ligand is held in 
place by a series of interactions that include 
hydrogen bonds of the backbone amide and 
carbonyl of F53 with the N3 and O2 of the 
ring and the π-stacking of the uracil by 
W52 and F190 (Figure 3C). The ribose C2 
hydroxyl group interacts with both the 
backbone carbonyl of Q51 and the hydroxyl 
group of Y224, whilst the C3 –OH group 
forms a hydrogen bond with the backbone 
amide of A227. 
The N-acetyl α-D-glucosamine in the 
active site is stabilized by a series of 
interactions that involve the anomeric C1 
hydroxyl group, at a distance of 3.6 Å from 
the phosphorous atom to which it was 
bound, and the guanidine group of R335, 
with hydrophobic interactions also 
established between the sugar and the 
aromatic ring of W334 (Figure 3C). The C2 
acetyl group oxygen, absent in UDP-Glc, 
forms a hydrogen bond (3.13 Å) with the 
backbone amide of G260. The same 
interaction can be seen between G405 and 
the sugar acetyl group in the structure of the 
pneumococcal transferase GtfA in complex 
with UDP and GlcNAc (PDB 4PQG) (33) 
and might contribute to the binding 
preference of SseK3 for UDP-GlcNAc 
compared to UDP-Glc. The structural 
position of G260 is substituted by a bulky 
glutamine side chain in clostridial toxin A 
and toxin B (Figure 3C) suggesting an 
explanation for preference of these toxins 
for UDP-Glc (19,20). 
The GlcNAc C4 and C6 hydroxyl groups in 
the structure of ligand bound SseK3 are 
locked in the active site by the side chain 
carboxylate of D191, which may explain 
why UDP-Gal, which has a C4 inverted 
stereochemistry compared to glucose, 
shows the lowest affinity for SseK3. 
The UDP and GlcNAc present in the SseK3 
catalytic pocket are in an arrangement 
similar to UDP-Glc bound to toxA and the 
hydrolysed UDP and Glc in toxB (Figure 
S2) (19,20). Differently from the clostridial 
toxins, the active site in SseK3 contains a 
glutamic acid residue, E258, 3.2 Å away 
from the anomeric carbon. This residue is 
conserved in all SseK effectors and NleB, 
but is replaced by an isoleucine in toxA, 
toxB and LT (19,20,31). Previous data 
suggested an important role of this residue 
for NleB1 function (22). 
 
Analysis of UDP-GlcNAc hydrolysis 
The presence of hydrolysed UDP-GlcNAc 
in the active site shows that, in the absence 
of a protein substrate, SseK3 can function 
as a hydrolase. To further explore the 
ability of SseK3 to hydrolyse UDP-GlcNAc 
we used 31P and 1H-NMR spectroscopy. At 
time 0 (Figure 4), the 1D 31P-spectrum of 
UDP-GlcNAc shows two doublets signals 
for the Pα, at -13.06ppm, and Pβ, at -
11.41ppm, for the diphosphate group of the 
UDP. A well-resolved quadruplet signal 
system in the 1D proton spectrum of the 
intact UDP-GlcNAc at 5.43ppm, can also 
be observed for the anomeric H1 proton of 
the glucose moiety, resulting from the H1-
H2 (3.56 Hz) and H1-Pβ (7.02 Hz) 
coupling (34,35). Addition of SseK314-335 
results in a progressive reduction of both 
NMR signals with time. The 31P spectrum 
(Figure 4A) shows the emergence of the Pα 
and Pβ doublet signals from UDP in a free 
form, whilst the quadruplet signal of the 
sugar C1 proton (Figure 4B) gradually 
disappears, substituted by a rising doublet 
at 5.12ppm corresponding to the same 
proton no longer attached to the β-
phosphorus of the UDP. The doublet has a 
3JH1,H2=3.58 Hz, a value typical for an α-
anomeric equatorial-axial stereochemistry 
for the sugar C1 (the β-form has a value 
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around 7-8 Hz)  (36,37). The chemical shift 
and proton-proton coupling constant of the 
glucosamine derived from the hydrolysis of 
the UDP-GlcNAc are identical to those in 
the spectrum of free N-acetyl α-D-
glucosamine. Moreover, mass spectrometry 
analysis of the reaction mixture does not 
show SseK3 modification (data not shown) 
excluding the possibility of intramolecular 
N-GlcNAcylation. 
The UDP-GlcNAc hydrolysis proceeds 
with a retention of the C1 chirality 
suggesting that SseK3 is a retaining 
glycosyltransferase enzyme. Although able 
to hydrolyse the ligand in the absence of its 
target substrate, SseK3 does it slowly. 
There is a reduction of 36 ± 2% of the 
signal intensities in the 31P-spctrum for the 
α− and β-phosphorus nuclei of the 
diphosphate group of the UDP-GlcNAc 
after 90 minutes at 30 °C. The peaks are 
still visible in the spectrum, albeit very 
close to the noise level, after the reaction is 
allowed to proceed for 12 hours. UDP-
GlcNAc hydrolysis is not observed with 
SseK314-333 (Figure S3A) – or in the 
absence of enzyme (Figure S3B) – 
indicating that together, the C-terminal 
residues W334 and R335 are necessary for 
SseK3 functional activity. 
 
Structure based analysis of SseK3 function 
To test the role of active site residues in the 
enzymatic activity of SseK3 in a functional 
framework, multiple amino acid 
substitutions were tested for their ability to 
modify the SseK3 substrate TRADD, as 
well as prevent NF-κB activation. We 
focused on amino acids from our structural 
analysis of SseK3 (Figure 3) that are 
required for coordination of UDP and 
GlcNAc and hence enzymatic activity. In 
addition, we were particularly interested to 
test whether E258 was critical for 
enzymatic activity as this residue is only 
conserved in NleB and SseK 
glycosyltransferases and has been shown to 
be required for the function of NleB1 (22).  
Individual SseK3 mutants were co-
transfected into 293ET cells together with 
FLAG-TRADD, and following anti-FLAG 
immuno-precipitation the GlcNAcylation of 
TRADD was analysed by immuno-blotting. 
As a control, transfected SseK3 K251A 
remained active like wild-type SseK3. In 
contrast, and as expected, mutation of the 
manganese coordinating DXD 
(D226A/D228A) motif ablated SseK3-
induced arginine-GlcNAcylation in cell 
lysates and the modification of immuno-
precipitated TRADD (Figure 5A) (8). The 
conserved glutamate (E258, predicted to 
coordinate GlcNAc), which is present in 
SseK and NleB proteins but not other 
structurally related 
glycosyltransferases, was also essential for 
arginine-GlcNAcylation of TRADD." In 
addition, mutations predicted to be required 
for coordination of uracil (W52A and 
Y224A) and GlcNAc (D191A, N259A and 
W334A) also eliminated SseK3-induced 
protein arginine-GlcNAcylation and more 
specifically, no modification of TRADD 
was detected (Figure 5A). Transfected 
SseK3 R194A (predicted to disrupt GlcNAc 
binding) appeared inactive but this mutant 
was not stably expressed and should be 
approached with caution (Figure 5A). 
Surprisingly, SseK3 with a mutation in the 
C-terminal residue R335 (to alanine) 
retained the ability to modify numerous 
proteins, including TRADD. However, the 
pattern of GlcNAcylation was different, 
with significantly fewer proteins modified 
when compared to wild-type SseK3 (Figure 
5A). 
Next, to test if enzymatic activity correlated 
with the ability of SseK3 to inhibit TNFα-
induced NF-κB activation, variants of 
SseK3 were transfected into 293ET cells 
together with an NF-κB-dependent 
luciferase reporter plasmid. We predicted 
that Q51A would still be catalytically active 
as it is the backbone carbonyl group and not 
the side chain that is involved in 
interactions with the ligand (Figure 2C). 
Interestingly, whilst we were not able to 
detect arginine-GlcNAcylation of TRADD, 
SseK3 Q51A was still a potent inhibitor 
NF-κB activation (Figure 5), suggesting 
that catalytic activity is retained but greatly 
reduced to below the level of detection. The 
side chain Nε of residue H247 is 4.4 Å 
away from the oxygen of the GlcNAc 
acetyl group, yet a similar finding was 
observed for SseK3 H247A, with inhibition 
of NF-κB activation occurring without 
detectable modification of TRADD (Figure 
5). This suggests that very low and non-
detectable levels of arginine-GlcNAcylation 
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are sufficient for SseK3-mediated inhibition 
of NF-κB activation, presumably due to the 
irreversible nature of the arginine 
modification. As the rest of the mutations in 
SseK3 that ablated the ability of the enzyme 
to arginine-GlcNAcylate TRADD (DXD, 
W52A, Y224A, D191A, E258A, N259A 
and W334A) also caused an inability of 
SseK3 to inhibit TNFα-induced NF-κB 
activation (Figure 5B and Figure S4), these 
data reveal that enzymatic activity is 
required for SseK3 function.   
 
Discussion 
Here we report the structure of the 
Salmonella arginine N-glycosyltransferase, 
SseK3, in its apo and ligand bound forms. 
The protein belongs to the GT-A family of 
glycosyltransferase enzymes and binds the 
ligand in a metal ion dependent manner via 
a DXD motif. The dynamic features of the 
last 15 residues of SseK3 are important as 
they experience a large conformational 
change upon ligand and metal binding. As 
suggested by solution NMR spectroscopy, 
the C-terminal residues are disordered in 
the unbound SseK3 structure, with 
structural reorganization following primary 
substrate binding, with an open-close 
catalytic cycle that, as in the case of a 
number of other glycosyltransferases, is 
likely to support SseK3 enzymatic activity 
(38,39). Residue W334 in the active site 
pocket occupies the same structural position 
as W520 in the catalytic fragment of the 
clostridial lethal toxin in complex with 
UDP-Glc and manganese (PDB 2VKD) 
(31) and it is conserved in toxin A (W519) 
(20) and toxin B (W520) (19) of the same 
organism (Figure 6 and S2). A tryptophan 
residue (W520) is also present in the active 
site of the L. pneumophila Lgt1 in complex 
with UDP-Glc and magnesium (PDB 3JSZ) 
(21) and in a structurally equivalent 
position in the unbound form of the α-toxin 
from C. novyi (PDB 2VK9) (31). As for the 
other toxins, W334 is a pivotal residue in 
the opening and closure of the catalytic 
cleft (40). In the ligand bound SseK3, its 
Nε1 forms a hydrogen bond with the UDP 
Pβ oxygen whilst the equivalent tryptophan 
residue (W519) in the structure of toxin A 
hydrogen bonds the glycosidic oxygen of 
the intact UDP-Glc (Figure S2B) (31). 
W334 is therefore in a position to stabilize 
the emerging negative charge of the former 
glycosidic oxygen transferred onto the 
UDP. Once the enzymatic reaction has 
occurred, the opening of the catalytic site 
and the release of the UDP reinitiate the 
cascade; indeed mutation of W334 ablates 
the catalytic and functional activity of 
SseK3. 
The presence of a hydrolysed UDP-GlcNAc 
in the protein active site suggests that 
SseK3 can function as a hydrolase. A 
process observed also in the case of toxin A 
(28) and toxin B (19). The hydrolysis of 
UDP-GlcNAc, in the absence of target 
substrate, is likely to be a proxy of its 
physiological glycosyltransferase activity 
and the observed release by NMR of a α-
anomeric form of GlcNAc, and presence of 
the same molecule in the enzyme active 
site, indicates that SseK3 is likely to be a 
retaining N-glycosylating enzyme.  
Reaction mechanisms of retaining 
glycosyltransferases have been 
controversial but it is generally accepted 
that they operate through the stabilization 
of an oxocarbenium-like transition state 
(41). Depending on the presence of a 
nucleophile in the active site correctly 
positioned on the β-face of the donor 
substrate, the reaction could proceed either 
via a front face or double inversion 
mechanism (42). For the clostridial O-
glycosylating toxins, in the absence of other 
available bases in the active site, the 
deprotonation of the acceptor nucleophile is 
carried out by the nucleotide Pβ oxygen. 
Following the formation of a transient 
oxocarbenium state,  the departure of the 
leaving sugar O1 and the formation of the 
new glycosidic bond occur on the same side 
of the anomeric carbon, retaining its 
stereochemistry (31). In the double 
displacement reaction, the presence of a 
nucleophile in close proximity to the 
anomeric carbon, directly under the sugar 
substrate β-face, stabilizes an 
oxocarbenium-like enzyme-ligand adduct. 
The reaction is then followed by a 
subsequent direct substitution by the target 
nucleophile at the opposite site of the 
anomeric C1 with a double inversion 
mechanism that retains the original carbon 
stereochemistry. This is the case for 
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lysozyme (43) and GT6 family member 
α3GalT (44). For these enzymes, a well-
located nucleophile within the active site - 
D52 for lysozyme and E317 for α3GalT - is 
a necessary element for the creation of a 
stereochemically inverted intermediate set 
for nucleophilic substitution. Despite their 
structural similarity, the presence of a 
glutamate side chain in the active site of 
SseK3, 3.2 Å from the anomeric carbon, 
suggests that this enzyme could operate as a 
retaining GT more similarly to α3GalT than 
to the clostridial toxins. The E258 side 
chain is important for SseK3 catalytic 
activity and is a conserved active site 
residue across the SseK effectors family 
and in NleB1, substituted by uncharged 
residues in structurally related toxins 
(Figure 6). Mutation into an alanine 
residue, similarly to the mutation of the 
equivalent residue in NleB1 (E253A), 
impairs the arginine-GlcNAcylation ability 
of SseK3 and NleB1 without, for the latter, 
abrogating binding to the target protein 
(22). To date the only available structure of 
an arginine-glycosylation enzyme is that of 
the Pseudomonas aeruginosa EarP that 
catalyses the transfer of a rhamnose 
molecule onto the bacterial translation 
elongation factor EF-P (16). EarP is an 
inverting glycosyltransferase belonging to 
the GT-B family and structurally unrelated 
to SseK3. Interestingly, EarP has three 
negatively charged residues in the active 
site (D13, D17 and E273), in close 
proximity to the sugar, that have been 
shown to be important in the catalytic 
activity and play a crucial role in the 
stabilization of the positive charge of the 
acceptor guanidino group. Mutation of 
those residues to alanine, as for the E258A 
mutation in SseK3, severely impairs EarP 
enzymatic activity without disrupting 
substrate binding (16).  
We, therefore, propose a catalytic 
mechanism, in which the glutamate side 
chain of E258 acts as the intramolecular 
nucleophile in the first step of a double 
displacement mechanism, forming an 
SseK3-GlcNAc intermediate state primed 
for the C1 nucleophilic attack to the sugar 
α-side by the guanidino group on the target 
arginine. E258 could aid in the selection of 
the arginine as the N-GlcNAcylation site 
and, similarly to the phosphate role in the 
clostridial toxins, increase the nucleophilic 
character of the acceptor by deprotonation 
of its side chain. A double displacement 
mechanism, where the C1-O1 bond is 
broken before the nucleophilic attack, could 
also be favoured by the presence of the 
guanidium group of R335 tucked in SseK3 
active site. R335 sits above the sugar O1, 
obstructing the access to the sugar α-side, 
sterically hindering a direct front-face 
reaction. 
In SseK3, the well-located R335 side chain 
hints to a potential intramolecular 
GlcNAcylation process. However, in vitro 
auto-GlcNAcylation of SseK314-335 is 
unlikely as NMR and mass spectrometry 
experiments only detected unbound 
glucosamine following UDP-GlcNAc 
hydrolysis by SseK3. Nevertheless, a 
specific role of this residue in SseK3 
function cannot be excluded. In the E. coli 
MurG, an O-GlcNAc GT-B family 
glycosyltransferase, the presence of a 
positively charged arginine residue (R261) 
in the active pocket provides extra stability 
for the negatively charged UDP emerging 
from the catalytic reaction (45). In the 
structure of the UDP and GlcNAc bound 
GtfA, an O-GlcNAc GT-B, an active site 
arginine residue (R328), crucial for 
catalytic activity, forms a strong hydrogen 
bond with the Pβ oxygen, stabilizing the 
negative charge generated from the 
processing of the substrate (33).  The active 
site of EarP has an arginine residue (R271), 
whose guanidino Nε1 is 2.5 Å from the 
phosphate oxygen that participates in the 
stabilization of the enzymatic products 
whose mutation into an alanine reduces 
EarP glycosylation activity (16). In SseK3, 
R335 is tucked in the active site at 2.62 Å 
from the sugar O1 and 3.24 Å from the 
oxygen beta phosphate and its mutation 
R335A induced a severely reduced 
arginine-GlcNAcylation pattern compared 
to wild-type SseK3 (Figure 5). As for EarP, 
this could reflect a decrease in enzymatic 
activity due to a decreased stabilization of 
the enzymatic products. Alternatively, as 
this residue is only conserved in SseK2, 
which like SseK3 localises to the Golgi 
network during infection (8), but is 
substituted by an alanine in SseK1 and 
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absent in NleB1, it could be indirectly 
involved in substrate specificity via reduced 
Golgi network association. 
During infection of macrophages, similarly 
to their E. coli ortholog, SseK1 and SseK3 
both function to mediate inhibition of NF-
κB activation as well as inhibition of an 
inflammatory necroptotic host cell death 
(8). The structure of SseK3 bound to its 
donor substrate hydrolysis products 
revealed which amino acids are necessary 
for ligand binding and hence arginine-
GlcNAcylation of TRADD and SseK3-
mediated inhibition of NF-κB activity. In 
addition to the ion-coordinating DXD 
motif, previous mutational analysis of 
NleB1, identified residue Y219 as required 
for function (22). This amino acid is 
conserved in SseK proteins (Y224) and is 
important for the coordination of the uracil 
of the UDP and therefore necessary for both 
SseK3 catalytic activity and function.  
SseK effector proteins share a high 
sequence identity but most of the conserved 
residues are those in the catalytic domain 
(Figure 1 and S5). Sequence variability is 
mainly concentrated around residues in the 
α-helical insertion suggesting that this 
region might direct substrate specificity. 
Despite its similarity to the other effectors, 
SseK2 does not show activity in cell-based 
assays (11). However, purified SseK2 can 
arginine-GlcNAcylate FADD in vitro, 
without forming a stable interaction, 
suggesting that this enzyme is functional 
(11). As all residues tested that are required 
for enzymatic activity in SseK3 are 
conserved in SseK2 it is not immediately 
clear why SseK2 is not active after 
translocation into host cells. In the absence 
of structural information for the other 
members of the SseK family, we created 
homology models of SseK1, SseK2 and 
NleB1 based on the SseK3 crystal structure 
(Figure 6). The distribution of surface 
charges shows that both SseK1 and NleB1 
have the active site surrounded by acidic 
residues whilst the surfaces of SseK2 and 
SseK3 appear to be more similar, with 72% 
sequence identity, having the ligand site 
surrounded by larger positively charged 
areas compared to SseK1. Also, as the C-
terminal residue in both SseK2 and SseK3 
is a positively charged residue (R348 and 
R334), substituted by a smaller side chain 
in SseK1 (A332) and absent in NleB1, the 
active site in SseK1 and NleB1 appears to 
be more accessible than in SseK2 and 
SseK3. Recently, it has been reported that 
NleB1 preferentially GlcNAcylates the 
death domain (DD) of FADD at residue 
R117 (23), although it can interact with and 
modify the DD of other proteins including 
TRADD and RIPK1 (9,10). Interestingly, 
SseK1 is the only SseK family member that 
can modify FADD (also at R117) after 
bacterial delivery into host cells (8). The 
structure of FADD-DD shows an extensive 
basic surface patch whose residues have 
been shown to be important in the 
interaction with Fas receptor (CD95) (46). 
In particular, mutation of R117, part of the 
FADD-DD extended positively charged 
surface, has been shown to abolish 
interaction with the cytoplasmic death 
domain of CD95 (47). Therefore, the 
contiguous acidic surfaces of SseK1 and 
NleB1 could act as a complementary 
surface, binding the death domain of FADD 
and allowing the side chain of residue R117 
to position itself in the active site for sugar 
transfer. The lack of activity in cell-based 
assays of SseK3 towards FADD, and the 
absence of a phenotype in Salmonella for 
SseK2, could then be the result of the 
interplay between a less accessible active 
site and altered substrate specificity, with 
SseK3 still able to modify TRADD.  
In summary, we have solved the first X-ray 
crystal structure of a GT-A arginine-
glycosyltransferase, identifying core-
conserved residues that are required for 
catalytic activity and virulence function of 
SseK3 allowing us to propose a potential 
enzymatic mechanism for N-arginine 
glycosylation.  
 
Experimental procedures 
Protein cloning, expression and 
purification 
Wild type SseK314-333 and SseK314-335 
constructs (Uniprot: A0A0H3NMP8) were 
cloned in pGEX-6P1 (GE Healthcare) 
vector by standard Gibson Assembly 
protocol (48) and expressed with a 
cleavable N-terminal GST tag. The proteins 
were expressed in E. coli BL21 (DE3) Gold 
in LB supplemented with 100 µg/ml 
ampicillin. Cells were grown at 30 °C until 
OD600 ≈ 0.6-0.8, induced with 0.5 mM 
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isopropyl β-­‐D-­‐1-­‐thiogalactopyranoside 
(IPTG) and incubated at 18 °C for 
overnight expression. Proteins were 
purified by GST-Sepharose affinity 
chromatography followed by cleavage of 
the GST N-terminal tag by 3C-protease and 
size-exclusion chromatography in 25 mM 
HEPES buffer pH 7.5, 150 mM NaCl and 
0.5 mM TCEP. The 3C-cleavage leaves 
amino acids GPLGS preceding the first 
amino acid of SseK3. SseK314-335 
purification was performed at 4oC, in the 
presence of EDTA-free protease inhibitor 
cocktail and 1mM PSMF in the lysis buffer. 
Seleno-methionine labelling of SseK314-333 
was achieved by using the Molecular 
Dimensions standard labelling protocol of 
M9 supplemented with L-selenomethionine 
with the auxotrophic strain E. coli 834 
(DE3) (49). SseK314-333 and SseK314-335 
concentrations were calculated using the 
values for ε at λ = 280 nm of 29,340 and 
34,840 M-1 cm-1, respectively. Mass 
spectrometry was used to check Seleno-
methionine incorporation and protein 
molecular masses. The server SWISS-
MODEL was used to create structural 
homology models of SseK1, SseK2 and 
NleB1 (50). 
 
SseK3 mutant plasmid construction 
SseK3 mutant variants were created by 
overlap mutagenesis PCR from the 
m4pGFP-SseK3 wild-type plasmid (8) and 
ligated into the mammalian expression 
vector m4pGFP to create plasmids 
encoding SseK3 mutants with an N-
terminal GFP-tag. All plasmids were 
checked by sequencing. 
Cell culture  
293ET cells (gift from Felix Randow) were 
cultured in Dulbecco’s modified Eagle’s 
medium (DMEM; Sigma) supplemented 
with 10% foetal calf serum (Sigma) at 37°C 
in 5% CO2. 
 
Isothermal titration calorimetry 
ITC experiments were performed at 293 K 
using a Microcal iTC200 calorimeter 
(Malvern). The protein solutions were 
prepared in buffer containing 25 mM 
HEPES buffer pH 7.5, 150 mM NaCl, 0.5 
mM TCEP and either 5mM MgCl2 or 
MnCl2. All experiments were performed by 
placing the solution containing SseK3 in 
the cell at concentrations of 50 µM and the 
solution containing the UDP-glucose 
derivatives in the syringe at 500 µM. The 
concentration of UDP-derivatives were 
estimated using the UDP extinction 
coefficient at λ = 262 nm of 9800 M-1 cm-1. 
For each titration 20 injections of 2 µL were 
performed. Integrated data, corrected for 
heats of dilution, were fitted using a 
nonlinear least-squares algorithm to a 1:1 
binding model, using the MicroCal Origin 
7.0 software package. The fitting 
parameters are ΔH (reaction enthalpy 
change in kcal·mol-1), Kb (equilibrium 
binding constant in M-1), and n (number of 
binding sites). The entropic contribution 
values (defined as -TΔS) were calculated 
from the values of ΔH and Kb. Each 
experiment was repeated at least twice and 
average values are reported in Table 1.  
 
Crystallization 
Initial screens for SseK314-333 were set up 
by sitting drop method at two protein 
concentrations (20 and 10 mg/mL) by 
combining 0.1 µl of protein solution with 
0.1 µl of reservoir. Commercially available 
crystallization screens were dispensed by 
using an automated Mosquito machine 
(TTP Labtech). The most promising initial 
crystal hits grew from drops set up with 10 
mg/mL protein solution in 0.1 M Tris pH 
8.5, 0.2 M NaCl and 25% PEG3350. No 
single crystals were obtained from the 
initial screening and multiple rounds of 
seeding were necessary to improve crystal 
quality. The seed stock was prepared by 
harvesting the small crystals, obtained in 
0.1 M Tris pH 8.5, 0.2 M NaCl and 25% 
PEG3350, in 50 µl solution of the same 
condition. The stock was then homogenised 
by vortexing for 30 sec using a Hampton 
seed bead. Sitting drops were dispensed by 
mixing 0.2 µl of protein solution at 9 
mg/ml, 0.18 µl of reservoir solution (0.1 M 
Tris pH 8.5, 0.2 M NaCl and 25% 
PEG3350) and 0.02 µl of seed stock. Single 
crystals of better diffraction quality could 
be grown with the Seleno-methionine 
SseK314-333 protein sample in the same 
condition but using a total protein 
concentration of 7 mg/mL. For X-ray data 
acquisition crystals were cryo-protected 
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with mother liquor containing 0.1 M TRIS 
pH 8.5, 0.2 M NaCl, 25% PEG3350 and 
20% ethylene glycol.  
To crystallise SseK314-335 in complex with 
UDP-GlcNac a stock solution was prepared 
by mixing the protein at 10 mg/mL with a 
three-fold molar excess of UDP-GlcNac 
(900 µM) and a final concentration of 
MnCl2 of 5 mM. Small single crystals were 
obtained in 0.1 M TRIS pH 8.0, 0.2 M NaI 
and 20% PEG3350 and improved by 
multiple rounds of seeding. For X-ray data 
acquisition crystals were cryo-protected 
with mother liquor containing 0.1 M TRIS 
pH 8.0, 0.2 M NaI, 20% PEG3350 and 30% 
trehalose. All the crystallization 
experiments were done at 20 °C. 
 
Data collection, phasing and refinement 
Despite keeping crystallisation and cryo-
protection protocols the same, in total four 
polymorphs were observed for SeMet-
labelled SseK314-333 crystals. Data from a 
monoclinic crystal were collected at the 
long-wavelength MX beamline I23 at 
Diamond Light Source (29) for 
experimental SAD phasing using a 
wavelength of λ = 2.7751 Å and processed 
with XDS (51). The anomalous 
substructure of 20 selenium and 20 sulphur 
atoms (corresponding to 4 molecules in the 
asymmetric unit) was located by SHELXD 
(52) at 3.5 Å  resolution. The substructure 
solution was confirmed by the presence of a 
4-fold non-crystallographic symmetry 
(NCS). Initial experimental electron density 
maps were of poor quality possibly due to 
the presence of a pseudo-translation and the 
anisotropy of the data. Since automatic 
building programs failed to provide a 
starting model, a careful inspection of the 
density map revealed the position of two 
helices that were placed as poly-alanine 
helices using Coot (53). The 4-fold NCS 
symmetry was applied to locate the 
corresponding helices in the asymmetric 
unit. The anomalous substructure and the 
initial model of the asymmetric unit 
comprising 8 helices were fed to CRANK2 
(54) to produce improved maps benefiting 
from 4-fold averaging and an almost 
complete model.    
Complete high-resolution data from for 
SeMet-labelled crystals of SseK314-333 were 
collected at Swiss Light Source (Villigen, 
Switzerland) and processed using DIALS 
(http://dials.diamond.ac.uk/). The structure 
of SeMet-labelled SseK314-333 was solved at 
a single wavelength of 0.97640 Å using the 
structural model obtained by long-
wavelength S-SAD as template in a 
molecular replacement with MOLREP (55). 
Data for SseK314-335 bound to UDP-GlcNAc 
and Mn2+ were collected at Diamond Light 
Source, I04 (Oxford, UK) and processed 
using XDS (51). The structure of SseK314-
335 co-crystallized in the presence of UDP-
GlcNAc and Mn2+ was solved using the 
apo-structure as template for molecular 
replacement with MOLREP (55). 
Models were iteratively improved by 
manual building in Coot (53) and refined 
using REFMAC5 (56) and Phenix (57). The 
parameters for the ligand stereochemistry 
were obtained from the standard Coot 
library. All structural figures were prepared 
in Pymol (Schrödinger, LLC) and Chimera 
(58). Further details on data collection and 
refinement statistics are summarised in 
Table 2. 
 
NF-κB reporter assays 
1 × 105 293ET cells (seeded the day before 
use) were transfected with a mixture of 50 
ng p4kB:Luc, 20 ng pRLTK and 500 ng 
m4pGFP-SseK3 variants (or m6pPAC-
FLAG-GFP control) using Lipofectamine 
2000 (Invitrogen). After 24 h of 
transfection, the cells were stimulated with 
50 ng/ml human TNFα (Sigma) for 17 h 
and luciferase activity was measured using 
the Dual Luciferase reporter assay system 
(Promega) and a Tecan Infinite200 PRO 
plate reader. NF-κB regulated luciferase 
activity was first normalised to Renilla 
luciferase activity and then the fold 
activation relative to unstimulated 
conditions of each SseK3 variant was 
calculated. 
 
TRADD-modification by SseK3 variants 
4 × 105 293ET cells were transfected for 40 
h with 1 µg m6pPAC-FLAG-TRADD and 
1 µg m4pGFP-SseK3 variant (or 1 µg 
m6pPAC-FLAG-GFP control) plasmid 
DNA using Lipofectamine 2000 
(Invitrogen).  Subsequently the cells were 
harvested and lysed for 30 min on ice in 
lysis buffer (150 mM NaCl, 0.3% (v/v) 
Triton X-100, 20 mM Tris-Cl (pH 7.4), 5% 
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glycerol, 5 mM EDTA, 1 mM PMSF, 1 
mM Benzamide, 2 µg/ml Aprotinin, 5 
µg/ml Leupeptin, 1 mM DTT) and 
cytoplasmic proteins isolated by 30 min 
centrifugation at 16,000 × g at 4°C. FLAG-
TRADD was then immuno-precipitated 
using anti-FLAG M2 Affinity Gel (Sigma) 
for 2 h at 4°C, washed and analyzed by 
SDS-PAGE and immuno-blotting using 
rabbit anti-FLAG (Sigma), rabbit anti-GFP 
(Invitogen), rabbit anti-Arginine-GlcNAc 
(EPR18251, Abcam), rabbit anti-tubulin 
(EPR16774, Abcam) antibodies and HRP-
conjugated anti-rabbit secondary antibody 
(Dako) for detection.  
 
Nuclear Magnetic Resonance 
All spectra were recorded at 25 °C on a 
Bruker AVANCE spectrometer operating at 
700 MHz, equipped with a cryogenically 
cooled quadruple resonance (1H, 15N, 13C 
and 31P) probe including Z-axis pulse field 
gradients. Data were acquired and 
processed with Topspin (version 3.5, 
Bruker). Reaction solutions of 10 µM of 
both SseK3 constructs (Santa Cruz 
Biotechnology, weight >98%) were 
prepared in 20 mM Tris pH 7.5, 100 mM 
NaCl, 0.5 mM TCEP and 5 mM MgCl2. 
500 µM UDP-GlcNAc added to the 
proteins solutions and hydrolysis was 
allowed to proceed at 30 °C under gentle 
stirring. The reaction was quenched at 
different time points by adding 10 mM 
EDTA (pH 7.5) and 5% D2O required for 
the magnetic field lock. The same reaction 
conditions were used to monitor UDP-
GlcNAc hydrolysis in the absence of 
enzyme. 1D 1H and 31P NMR spectra were 
recorded using the standard excitation 
sculpting pulse sequences zgesp and 
zgpg30 implemented in Topspin acquisition 
software.
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Table 1 
Thermodynamic quantities for the interaction of SseK3 constructs and UDP-glucose derivatives 
Protein/Ligands   Kd  ΔH  -TΔS  Sites 
     µM  kcal/mol cal/mol deg  
SseK314-335/no cation  nbd  nbd  nbd  nbd 
SseK314-335/UDP-GlcNAc/Mg2+ 10 ± 1.0 -7.4 ± 0.4 0.7 ± 0.1 0.8 ± 0.1 
SseK314-335/UDP-GlcNAc/Mn2+ 1.9 ± 0.5 -15.8 ± 0.3 8.1 ± 0.2 0.9 ± 0.1 
SseK314-335/UDP-Gal/Mn2+  6.7 ± 0.8 -8.9 ± 0.3 2.0 ± 0.4 0.8 ± 0.1 
SseK314-335/UDP-Glu/Mn2+  2.6 ± 0.1 -11.4 ± 0.8 4.0 ± 0.8 0.9 ± 0.1 
SseK314-333/UDP-GlcNAc/Mn2+ 6.3 ± 0.5 -8.8 ± 0.5 1.9 ± 0.6 0.8 ± 0.1 
SseK314-333/UDP-Gal/Mn2+  7.7 ± 1.6 -7.1 ± 0.4 2.6 ± 0.5 0.8 ± 0.1 
SseK314-333/UDP-Glu/Mn2+  5.6 ± 1.2 -9.8 ± 0.5 2.8 ± 0.6 0.7 ± 0.1 
nbd: no binding detected 
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Table 2 
Crystallographic data collection and refinements statistics 
    SseK3long-wavelength SseK3apo  SseK3UDP-GlcNAc 
Residues   14-333   14-333   14-335 
PDB ID      6EYR   6EYT  
Data Collection statistics  
Wavelength (Å)  2.7552   0.97640  0.97950 
Resolution range (Å)  49.88 – 2.1  58.24  - 2.2  48.01  - 2.21 
Highest resolution range (Å) 2.175 – 2.1  2.279  - 2.2  2.289  - 2.21 
Space group   P21   P212121     P212121 
Cell dimensions 
a, b, c (Å)  96.08 75.02 101.89 73.61 86.05 95.22 73.97 85.94 96.03 
α, β, γ (°)  90 109.52 90  90 90 90  90 90 90 
Total reflections  1430296 (110092) 230518 (23312)  186687 (10819) 
Unique reflections  62053 (4764)  31246 (3104)  30891 (2847) 
Multiplicity   23.0 (22.3)  7.4 (7.5)  6.0 (3.8) 
Completeness (%)  77.31 (59.94)  99.42 (99.52)  98.54 (91.72) 
Mean I/sigma(I)  13.34 (1.79)  7.79 (2.80)  6.99 (1.18) 
Wilson B-factor  39.47   23.08   31.1 
R-merge   0.1655 (1.796)  0.1509 (0.6784)  0.1806 (1.034) 
R-meas   0.1693 (1.84)  0.1624 (0.7296)  0.1974 (1.185) 
R-pim   0.03484 (0.3808) 0.05927 (0.2654) 0.07853 (0.564) 
CC1/2   0.997 (0.707)  0.994 (0.888)  0.995 (0.55) 
CC*    0.999 (0.91)  0.999 (0.97)  0.999 (0.842) 
Phasing    
Resolution cutoff (Å) 3.5    
Sites (found/expected) 40 / 40   
Refinement statistics    
Reflections used in refinement   31203 (3092)  30886 (2847) 
Reflections used for R-free    1543 (131)  1530 (124) 
R-work      0.2171 (0.2755)  0.1963 (0.2676) 
R-free      0.2582 (0.2966)  0.2408 (0.2891) 
CC (work)      0.950 (0.846)  0.959 (0.783) 
CC (free)      0.918 (0.796)  0.941 (0.784) 
Number of non-hydrogen atoms   5185   5311 
Protein atoms     4867   4940 
Ligand atoms     -   86 
Solvent atoms     318   285 
Protein residues     610   618 
rmsd bond lengths (Å)    0.003   0.005 
rmsd angles (°)     0.67   0.78 
Ramachandran favored (%)    98.51   98.37 
Ramachandran allowed (%)    1.49   1.63 
Ramachandran outliers (%)    0   0 
Rotamer outliers (%)     0   0.37 
Clashscore      7.05   8.86 
Average B-factor (Å2)    30.15   33.58 
Macromolecules (Å2)     29.95   33.3 
Solvent (Å2)      33.27   37.94 
Ligands (Å2)      -   35.49 
Highest-resolution shell values are given in parentheses. 
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Figure 1. Binding affinity of the ligand to SseK3. Isothermal Titration Calorimetry curves for 
the interaction of SseK314-333 and SseK314-335 with UDP-Galactose (UDP-Gal), UDP-Glucose 
(UDP-Glc) and UDP-Glucosamine (UDP-GlcNAc). The experiments were executed in the 
presence of 5 mM MnCl2. The integrated heat signals for the interaction were integrated as a 
function of the molar ratio of titrant to protein in the cell. The data were fitted to a 1:1 binding 
model and the dissociation constants are reported for each experiment. 
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Figure 2. Structure of ligand-free and bound SseK3. Ribbon representation of the structure of the 
unbound SseK314-333 (A) and SseK314-335/UDP-GlcNAc/Mn2+ complex (B). The figure shows the 
central GT-A catalytic domain that binds the ligand substrate and highlights the α-helical 
insertion that shows variability in the two protomers in the asymmetric crystallographic unit. 
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Figure 3. Close-up of the catalytic core of SseK3. (A) Sequence alignment of the SseK effectors 
family and their E. coli ortholog NleB. The conserved residues involved in the metal 
coordination, including the DXD motif, are reported as magenta dots on the sequence alignment. 
(B) Close-up of the residues that participate in the coordination of the Mn2+ ion and (C) in the 
ligand interaction. (D) Downfield region of the proton NMR spectra of SseK3 showing that the 
addition of Mg2+ and UDP-GlcNAc quashes the sharp resonances present in the spectrum of 
unbound SseK3. The asterisks show the resonances from a complex multiplet around 6ppm 
originated from the UDP-GlcNAc (green) and the resonance at 10ppm from the Hε1 of W334 
(blue). 
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Figure 4. SseK314-335 hydrolyses UDP-GlcNAc in UDP and free N-acetyl α-D-glucosamine. 
Phosphorous (A) and proton (B) NMR spectra of a 500 µM solution of UDP-GlcNAc in the 
presence of 10 µM SseK314-335. The spectra were recorded at different time points: 0 min (blue), 
5 min (red), 15 min (green), 30 min (purple), 90 min (yellow) and 12 hours (orange). (C) UDP-
GlcNAc hydrolysis reaction: the Pα and Pβ doublets and the H1 multiplets are assigned in the 
relative spectra and highlighted on the chemical structures of the ligand in its intact and 
hydrolysed form 
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Figure 5. Screening SseK3 putative catalytic mutants for loss of Arg-GlcNAcylation towards 
TRADD. (A) 293ET cells co-transfected with FLAG-TRADD and the indicated GFP-tagged 
variants of SseK3 were lysed and inputs and anti-FLAG immunoprecipitates were analysed by 
immunoblot. Arg-GlcNAcylation of post-nuclear supernatants (input) and immunoprecipitated 
FLAG-TRADD was tested using anti-Arg-GlcNAc antibody. Expression of GFP-tagged SseK3 
variants was tested using anti-GFP antibody in cell lysates. Antibodies to tubulin were used as a 
loading control. The shown immunoblots are representative of 4 independent experiments. (B) 
293ET cells were co-transfected with an NF-κB-dependent luciferase reporter plasmid, pTK-
Renilla luciferase and the indicated GFP-tagged SseK3 mutants for 24 hours prior to overnight 
stimulation with 50 ng/ml TNFα. Luciferase activity was measured in cell lysates and results are 
presented as the fold activation relative to unstimulated controls expressing each SseK3 variant. 
Data are the mean +/- s.e.m of 5 independent experiments. Cell lysates from (B) were analysed 
by immuno-blot in supplementary Figure S4. * P < 0.05. DXD corresponds to the SseK3 
D226A/D228A mutant.  
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Figure 6. Glycosyltransferase structural alignment and SseK1, SseK2 and NleB1 homology 
structural models. Upper panel: Structural alignment of SseK3 with C. sordelli LT (PDB 2VKD, 
19% sequence identity), C. difficile toxin A (3SRZ, 17%) and toxin B (2BVL, 15%), L. 
pneumophila Lgt1 (3JSZ, 11%) and P. asymbiotica toxin (4MIX, 19%). The catalytic important 
E258 residue is marked with an asterisk in the alignment. Lower panel: Solvent-accessible 
surface representation coloured according to the electrostatic potential (positive blue, negative 
red) of the structure of SseK314-335 bound to its UDP-GlcNAc ligand and homology structural 
models of SseK1 (55% sequence identity with SseK3), Ssek2 (72%) and NleB1 (53%). Ligand 
bound in the active site is highlighted. 
	  
